Effective measures to prevent ovarian hyperstimulation syndrome (OHSS) rema
in controversial, It became almost 'common knowledge' that there is no stra
tegy that may completely prevent OHSS. Extensive clinical experience (albei
t not derived from prospective randomized studies) clearly documents the ab
ility of a single administration of gonadotrophin-releasing hormone (GnRH)
agonist to effectively trigger ovulation, while completely eliminating any
threat of clinically significant OHSS, This strategy cannot be used if the
pituitary is down-regulated (as is the case in most assisted reproductive c
ycles today), however, the newly-introduced GnRH antagonists open new oppor
tunities for implementing this strategy, since the pituitary preserves its
responsiveness to GnRH agonists, Combining GnRH antagonist-based ovarian st
imulation (particularly in 'high responders'). with GnRH agonist-driven ovu
lation triggering will make severe OHSS a disease of the past in assisted r
eproduction.